Neogenomics (NEO) EBT Margin (2010 - 2026)
Neogenomics' (NEO) quarterly EBT Margin came in at 0.91% in Q2 2026, up 2617.0% YoY from 0.03% in Q2 2025, and up 109.62% on a QoQ basis from 9.42% in Q1 2026.
Neogenomics (NEO) EBT Margin (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has 17 years of EBT Margin data on file, last reported at 0.91% in Q2 2026.
- Quarterly EBT Margin rose 2617.0% year-over-year to 0.91% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 7.12% (up 818.0% YoY) and the FY2025 annual result came in at 15.16%, down 295.0% from the prior year.
- EBT Margin improved to 0.91% in Q2 2026, from 9.42% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 0.91% in Q2 2026 to a low of 45.37% in Q1 2022.
- A 5-year average of 17.38% and a median of 14.69% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 9314 bps — and 2026, when it soared 2617 bps.
- Tracing NEO's EBT Margin over 5 years: stood at 18.4% in 2022, then jumped by 47 bps to 9.83% in 2023, then increased by 5 bps to 9.38% in 2024, then soared by 30 bps to 6.52% in 2025, then jumped by 114 bps to 0.91% in 2026.
- The last three EBT Margin figures came in at 0.91% (Q2 2026), 9.42% (Q1 2026), and 6.52% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 0.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.91% |
| Mar 31, 2026 | -9.42% |
| Dec 31, 2025 | -6.52% |
| Sep 30, 2025 | -14.05% |
| Jun 30, 2025 | -25.27% |
| Mar 31, 2025 | -15.27% |
| Dec 31, 2024 | -9.38% |
| Sep 30, 2024 | -10.64% |
| Jun 30, 2024 | -11.56% |
| Mar 31, 2024 | -17.72% |
| Dec 31, 2023 | -9.83% |
| Sep 30, 2023 | -14.12% |
| Jun 30, 2023 | -18.13% |
| Mar 31, 2023 | -24.57% |
| Dec 31, 2022 | -18.40% |
| Sep 30, 2022 | -30.77% |
| Jun 30, 2022 | -32.81% |
| Mar 31, 2022 | -45.37% |
| Dec 31, 2021 | -35.16% |
| Sep 30, 2021 | -19.10% |